Eosinophilic esophagitis (EoE) has been steadily increasing in prevalence and incidence over the past three decades.
Today, EoE has evolved from a rare case-reportable condition to a disease that is commonly encountered in the clinic and endoscopy suite and is a major cause of upper gastrointestinal morbidity and increasing healthcare costs.
Delays in diagnosis persist and management of the disease can be complex.
While significant advances in the treatment of EoE have been made, studies show many clinicians continue to prescribe therapies with limited effectiveness.
Moreover, clinicians often forego efforts to engage patients with EoE in shared decision-making, despite evidence demonstrating that patients who participate in decisions around treatment report higher levels of treatment satisfaction.
To provide patient-centered EoE care, clinicians must recognize and navigate
the diagnostic and management challenges of the condition and tailor therapy selection considerate of patient preferences and values.
